BNP Paribas Financial Markets’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.3M | Sell |
860,500
-96,526
| -10% | -$3.95M | 0.02% | 796 |
|
|
2026
Q1 | $31.8M | Buy |
957,026
+273,373
| +40% | +$8.15M | 0.02% | 900 |
|
|
2025
Q4 | $20.4M | Buy |
683,653
+612,189
| +857% | +$20M | 0.01% | 1168 |
|
|
2025
Q3 | $2.58M | Sell |
71,464
-7,516
| -10% | -$248K | ﹤0.01% | 2440 |
|
|
2025
Q2 | $2.84M | Sell |
78,980
-472,049
| -86% | -$17.6M | ﹤0.01% | 2234 |
|
|
2025
Q1 | $21.7M | Buy |
551,029
+491,319
| +823% | +$16.5M | 0.01% | 996 |
|
|
2024
Q4 | $1.8M | Sell |
59,710
-58,275
| -49% | -$1.67M | ﹤0.01% | 2428 |
|
|
2024
Q3 | $2.76M | Sell |
117,985
-24,661
| -17% | -$539K | ﹤0.01% | 1867 |
|
|
2024
Q2 | $2.54M | Buy |
142,646
+56,045
| +65% | +$894K | ﹤0.01% | 1777 |
|
|
2024
Q1 | $1.32M | Sell |
86,601
-207,006
| -71% | -$3.3M | ﹤0.01% | 2323 |
|
|
2023
Q4 | $5.01M | Sell |
293,607
-874,176
| -75% | -$10.2M | 0.01% | 1403 |
|
|
2023
Q3 | $9.76M | Buy |
1,167,783
+598,994
| +105% | +$8.35M | 0.01% | 906 |
|
|
2023
Q2 | $14.1M | Buy |
568,789
+209,537
| +58% | +$5.41M | 0.02% | 771 |
|
|
2023
Q1 | $5.4M | Buy |
359,252
+167,841
| +88% | +$2.55M | 0.01% | 1206 |
|
|
2022
Q4 | $2.26M | Sell |
191,411
-135,512
| -41% | -$984K | ﹤0.01% | 1694 |
|
|
2022
Q3 | $1.94M | Buy |
326,923
+169,010
| +107% | +$1.11M | ﹤0.01% | 1984 |
|
|
2022
Q2 | $671K | Buy |
157,913
+49,051
| +45% | +$306K | ﹤0.01% | 2483 |
|
|
2022
Q1 | $1.04M | Sell |
108,862
-671
| -0.6% | -$7.77K | ﹤0.01% | 2295 |
|
|
2021
Q4 | $2.08M | Buy |
109,533
+86,718
| +380% | +$2.25M | ﹤0.01% | 1991 |
|
|
2021
Q3 | $759K | Buy |
22,815
+18,199
| +394% | +$563K | ﹤0.01% | 2531 |
|
|
2021
Q2 | $179K | Sell |
4,616
-14,494
| -76% | -$569K | ﹤0.01% | 2892 |
|
|
2021
Q1 | $921K | Sell |
19,110
-81,498
| -81% | -$3.92M | ﹤0.01% | 2184 |
|
|
2020
Q4 | $5.23M | Buy |
100,608
+74,504
| +285% | +$2.52M | 0.01% | 1106 |
|
|
2020
Q3 | $699K | Buy |
26,104
+14,077
| +117% | +$324K | ﹤0.01% | 2005 |
|
|
2020
Q2 | $234K | Sell |
12,027
-30,850
| -72% | -$497K | ﹤0.01% | 2431 |
|
|
2020
Q1 | $422K | Buy |
42,877
+32,782
| +325% | +$414K | ﹤0.01% | 2439 |
|
|
2019
Q4 | $112K | Sell |
10,095
-1,976
| -16% | -$15K | ﹤0.01% | 3243 |
|
|
2019
Q3 | $67.8K | Buy |
12,071
+5,099
| +73% | +$35.5K | ﹤0.01% | 3328 |
|
|
2019
Q2 | $60.3K | Sell |
6,972
-6,145
| -47% | -$46.5K | ﹤0.01% | 3304 |
|
|
2019
Q1 | $105K | Buy |
13,117
+9,255
| +240% | +$50K | ﹤0.01% | 3092 |
|
|
2018
Q4 | $15.8K | Sell |
3,862
-6,920
| -64% | -$34.4K | ﹤0.01% | 3185 |
|
|
2018
Q3 | $60.4K | Sell |
10,782
-404
| -4% | -$4.62K | ﹤0.01% | 2971 |
|
|
2018
Q2 | $147K | Buy |
11,186
+422
| +4% | +$5.8K | ﹤0.01% | 2594 |
|
|
2018
Q1 | $153K | Sell |
10,764
-745
| -6% | -$9.52K | ﹤0.01% | 2959 |
|
|
2017
Q4 | $94.4K | Buy |
11,509
+6,449
| +127% | +$56.3K | ﹤0.01% | 3335 |
|
|
2017
Q3 | $60K | Sell |
5,060
-321
| -6% | -$3.66K | ﹤0.01% | 3052 |
|
|
2017
Q2 | $54.1K | Buy |
5,381
+5,066
| +1,608% | +$56.7K | ﹤0.01% | 3149 |
|
|
2017
Q1 | $3.67K | Sell |
315
-1,781
| -85% | -$12.8K | ﹤0.01% | 3380 |
|
|
2016
Q4 | $9.75K | Sell |
2,096
-631
| -23% | -$3.7K | ﹤0.01% | 3469 |
|
|
2016
Q3 | $21.1K | Buy |
2,727
+1,292
| +90% | +$8.31K | ﹤0.01% | 2863 |
|
|
2016
Q2 | $8.7K | Buy |
+1,435
| New | +$11.7K | ﹤0.01% | 2974 |
|
|
2016
Q1 | – | Sell |
-3,700
| Closed | -$44.1K | – | 3046 |
|
|
2015
Q4 | $44.1K | Sell |
3,700
-3,855
| -51% | -$48.7K | ﹤0.01% | 2391 |
|
|
2015
Q3 | $76.2K | Buy |
7,555
+4,614
| +157% | +$68.7K | ﹤0.01% | 2564 |
|
|
2015
Q2 | $48.8K | Buy |
2,941
+2,295
| +355% | +$36.3K | ﹤0.01% | 2508 |
|
|
2015
Q1 | $10K | Buy |
+646
| New | +$9.78K | ﹤0.01% | 2746 |
|
|
2014
Q4 | – | Sell |
-1,718
| Closed | -$18.3K | – | 3071 |
|
|
2014
Q3 | $18.3K | Buy |
1,718
+1,042
| +154% | +$9.66K | ﹤0.01% | 3229 |
|
|
2014
Q2 | $6.35K | Buy |
676
+78
| +13% | +$499 | ﹤0.01% | 2478 |
|
|
2014
Q1 | $3.19K | Sell |
598
-166
| -22% | -$983 | ﹤0.01% | 2528 |
|
|
2013
Q4 | $2.98K | Buy |
+764
| New | +$3.09K | ﹤0.01% | 3429 |
|
Other funds holding TGTX
SCM
CAM
BNP Paribas Financial Markets's TGTX Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its TG Therapeutics (TGTX) stake by 10% in Q2 2026, selling an estimated $3.95M and leaving 860,500 shares worth $47.3M. The position accounts for 0.02% of the portfolio, ranked #796.
BNP Paribas Financial Markets first reported a position in TGTX in Q4 2013 and has held it in 49 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- BNP Paribas Financial Markets held 860,500 shares of TG Therapeutics worth $47.3M as of Q2 2026.
- BNP Paribas Financial Markets sold 96,526 TG Therapeutics shares in Q2 2026, an estimated $3.95M.
- TG Therapeutics made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #796 holding.
- BNP Paribas Financial Markets first reported a position in TG Therapeutics in Q4 2013 and has held it in 49 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.